Journal of the American Chemical Society
Article
(f) MacCarthy-Morrogh, L.; Townsend, P. A.; Purohit, A.; Hejaz, H. A.
M.; Potter, B. V. L; Reed, M. J.; Packham, G. Cancer Res. 2000, 60,
5441. Review on enantiomeric steroids: (g) Biellmann, J. F. Chem. Rev.
2003, 103, 2019.
(40) (a) Ficini, J.; Krief, A. Tetrahedron Lett. 1969, 10, 1431.
(b) Ficini, J. Tetrahedron 1976, 32, 1449.
(41) (a) Ynamides are more stable and conveniently prepared than
ynamines and have recently attracted much attention in organic
synthesis thanks to their extraordinarily diverse chemistry but are still
rarely used in enantioselective reactions; see: (b) Evano, A.; Coste, K.;
Jouvin. Angew. Chem., Int. Ed. 2010, 49, 2840−2859;(c) Angew. Chem.
2010, 122, 2902−2921. (d) DeKorver, K. A.; Li, H.; Lohse, A. G.;
Hayashi, R.; Lu, Z.; Zhang, Y.; Hsung, R. P. Chem. Rev. 2010, 110,
5064.
and r2p is determined mostly by the charge density at the
corresponding carbon atom. We suggest that the highly
deshielded carbon resonance at δ 188.3 in 7a results from
the polarization caused by the coordination to the dicationic
ruthenium PNNP fragment, which lowers the energy of the
enone π*-orbital (small ΔE) and contracts the p-orbital
coefficient (reduced electron density on C). (b) Wehrli, F. W.;
Marchand, A. P.; Wehrli, S. Interpretation of Carbon-13 NMR
Spectra, 2nd ed.; Wiley: Chichester, 1988; pp 34−38.
(22) Houk, K. N.; Strozier, R. W. J. Am. Chem. Soc. 1973, 95, 4094.
(23) Cheng, T.-Y.; Szalda, D. J.; Zhang, J.; Bullock, R. M. Inorg.
Chem. 2006, 45, 4712.
(24) Gomberg, M. J. Am. Chem. Soc. 1900, 22, 757.
(25) Jung, M. E.; Brown, R. W. Tetrahedron Lett. 1978, 31, 2771.
(26) Jung, M. E.; Pan, Y.-G. J. Org. Chem. 1977, 42, 3961.
(27) Selected examples: (a) Weng, W.; Chen, C.-H.; Foxman, B. M.;
Ozerov, O. V. Organometallics 2007, 26, 3315. (b) O’Connor, E. J.;
Kobayashi, M.; Floss, H. G.; Gladysz, J. A. J. Am. Chem. Soc. 1987, 109,
4837. (c) Tam, W.; Lin, G. Y.; Wong, W. K.; Kiel, W. A.; Wong, V. K.;
Gladysz, J. A. J. Am. Chem. Soc. 1982, 104, 141. (d) Kiel, W. A.; Lin,
G.-Y.; Gladysz, J. A. J. Am. Chem. Soc. 1980, 102, 3299.
(42) Li, H.; Hsung, R. P.; DeKorver, K. A.; Wei, Y. Org. Lett. 2010,
12, 3780.
(43) A few crystals suitable for X-ray crystallography were obtained
by slow diffusion of hexane into a CD2Cl2 solution of racemic 7a
(obtained by hydride abstraction from 5a). Several attempts were
made to use the same protocol to isolate either racemic or enantiopure
7a on a larger scale (50−100 mg). In all cases, only intractable oils
were obtained.
(28) Carter, C. A. G.; Casty, G. L.; Stryker, J. M. Synlett 2001, 1046.
(29) (a) Liotta, D.; Barnum, C.; Puleo, R.; Zima, G.; Bayer, C.; Kezar,
H. S. J. Org. Chem. 1981, 46, 2920. (b) Baker, R.; Selwood,
D. L.; Swain, C. J.; Webster, N. M. H. J. Chem. Soc., Perkin Trans. 1
1988, 3, 471.
(30) Schultz, A. G.; Holoboski, M. A. Tetrahedron Lett. 1993, 34,
3021.
(31) Chou, H.-H.; Hsieh, M.-T.; Liu, H.-J.; Ly, T. W.; Wu, H.-M.;
Wu, Y.-K. Org. Lett. 2009, 11, 1673.
(44) In fact, the X-ray structures of the tert-butyl analogues 5a and 7a
indicate that little structure rearrangement occurs upon hydride
abstraction from the enolato complex; see above.
(45) As the C(49)···Ru−P(1)−C(1) dihedral angle is smaller in the
enone complex 7a than in the corresponding enolato derivative 5a
because of the increased π−π interactions in the former complex (see
above and Table 1), we suggest that the shielding in 7b and 7c may be
even more efficient than indicated by the C(49)···Ru−P(1)−C(1)
values available for the enolato complexes 5b and 5c.
(32) (a) Nomenclature of Inorganic Chemistry: IUPAC Recommenda-
tions 2005; Connelly, N. G.; Hartshorn, R. M.; Damhus, T.; Hutton,
A. T., Eds.; RSC Publishing: Cambridge, 2005; pp 174−199. (b) Sloan,
T. E. In Topics in Inorganic and Organometallic Stereochemistry;
Geoffroy, G. L., Ed.; Topics in Sterochemistry; Wiley: New York, 1981;
Vol. 12, pp 1−36. (c) Von Zelevsky, A. Stereochemistry of Coordination
Compounds; Wiley: Chichester, 1996. (d) Knof, U.; von Zelevsky, A.
Angew. Chem., Int. Ed. 1999, 38, 302−322.
(46) Prepared according to Scheme 4a−c by adding β-ketoester 3b to
2, followed by deprotonation with triethylamine and hydride
abstraction with tritylium hexafluorophosphate without chromato-
graphic separation. The 31P NMR spectra of the reaction solution
taken at each step showed that the diastereoisomeric ratio remained
constant at ca. 70:30.
(47) The reason for the increased enantioselectivity observed upon
activation by the hydride abstraction pathway (even when the minor
diasteroisomer 7c is used as catalyst, Table 3, entry 11) is probably
related to the higher purity of the catalysts obtained with this method
as compared to double chloride abstraction with (Et3O)PF6. In fact,
(Et3O)PF6 is a highly reactive species whose slow degradation upon
storing produces traces of strong acids that may interfere with the
catalytic reaction. A further advantage of hydride abstraction is that the
reaction is instantaneous instead of progressing overnight, like the
generation of 2 from 1 by chloride abstraction with (OEt3)PF6.
(48) The signal assignments have been confirmed by adding a
CD2Cl2 solution of the reaction products (16 or 18) to 2 (see
Supporting Information). Chemical shifts (162 MHz in CD2Cl2):
[Ru(16b)(PNNP)]2+ δ 49.1/62.9 (major) and 47.1/61.8 (minor);
[Ru(18)(PNNP)]2+ δ 43.9/59.7 (major) and 45.2/61.5 (minor).
(49) The stoichiometric reaction of 7a with Dane’s diene (15)
reached completion in about 30 min instead of less than 15 min with
7b. Then, addition of 6a (1 equiv) regenerated [Ru(6a)(PNNP)]2+
(7a) (60%) after 30 min in CD2Cl2 (Table 5, entry 4), as opposed to
35% in case of the exchange of the ruthenium-bound product 16b for
6b (entry 1).
(50) (a) This effect should not be confused with the thermodynamic
product inhibition often encountered in enzymes, in which both
substrate and product bind to the catalyst (the enzyme) in rapidly
established equilibria that progressively shift toward product
coordination as the substrate concentration decreases; see: (b) Biss-
wanger, H. Enzyme Kinetics: Principles and Methods, 2nd ed.; Wiley:
Weinheim, 2008; pp 88−119.
(51) In contrast, the optimized Diels−Alder conditions for 2,3-
dimethylbutadiene (9) require pure CH2Cl2 as solvent (Table 2,
entries 1 and 6).15 To understand this feature, the stoichiometric
Diels−Alder reaction of 7b was repeated with diene 9 under the same
(33) This complex, which was obtained upon attempts to crystallize
the β-ketoester complex 4a, is probably formed by acid-catalyzed
hydrolysis of 3a; see ref 12a.
(34) Huheey, J. E.; Keiter, E. A.; Keiter, R. L. Inorganic Chemistry:
Principles of Structure and Reactivity, 4th ed.; Harper Collins College
Publishers: New York, 1993; pp A−30.
(35) Interestingly, this rearrangement does not involve the P(1)
atom connected to the C(1)−C(6) phenyl ring, the C(49)−Ru−P(1)
angle remaining nearly unchanged (92.52(6) vs 91.27(5)°, Table 1), as
compared to the large reduction of the angle between the substrate-
ring and phenyl-ring planes (see above).
(36) (a) Electronic factors are believed to influence the diastereo-
selectivity of Diels−Alder reactions via secondary orbital overlaps
(SOO).36b,c However, the difference in SOO between the keto and the
ester carbonyl group must be small in comparison to the effect of the
steric difference between cyclopentenone ring and ester moiety, see
ref 15b. (b) Fleming, I. Molecular Orbitals and Organic Chemical
Reactions, Student ed., 1st ed.; John Wiley & Sons Ltd.: Chichester,
2009; pp 235−238. (c) Ohwada, T. In Topics in Current Chemistry,
Inagaki, S., Ed.; Springer: Berlin/Heidelberg, 2009; Vol. 289, pp 161−
171.
(37) Schotes, C.; Mezzetti, A. J. Org. Chem. 2011, 76, 5862.
(38) Trost, B. M.; Jiang, C. Synthesis 2006, 369.
(39) (a) Yeung, Y. Y.; Chein, R. J.; Corey, E. J. J. Am. Chem. Soc.
2007, 129, 10346. (b) Canales, E.; Corey, E. J. Org. Lett. 2008, 10,
3271. (c) Vicker, N.; Lawrence, H.; Allan, G.; Bubert, C.; Smith, A.;
Tutill, H.; Purohit, A.; Day, J.; Mahon, M.; Reed, M.; Potter, B.
ChemMedChem 2006, 1, 464. (d) Fischer, D. S.; Woo, L. W. L.; Mahon,
M. F.; Purohit, A.; Reed, M. J.; Potter, B. V. L Bioorg. Med. Chem. 2003,
11, 1685. (e) Labrie, F. Mol. Cell. Endocrinol. 1991, 78, C113.
1342
dx.doi.org/10.1021/ja210372u | J. Am. Chem.Soc. 2012, 134, 1331−1343